Neurology of Hereditary Molecular & Metabolic Disease of Children
Written in a readily-accessible, highly-readable style, this unique reference offers a sound starting point and clinical step-by-step approach to treating the complex and often baffling neurogenetic diseases found in children. Conveniently organized by age groups from prenatal diagnosis to neonate to childhood, each chapter begins by describing symptoms (similar to the way a patient would present), and then guides you through confirming the diagnosis and choosing the appropriate course of therapy.
Completely updated to reflect the significant advances made following the discovery of the DNA sequence on the human genome, the Third Edition of Neurology of Hereditary Metabolic Diseases of Children clarifies the complicated genetics and biochemistry of these illnesses and will prove to be invaluable to the non-specialist and specialist alike.
New to the Third Edition:
Tables categorizing diseases by mechanisms
Treatment for disorders that previously had no known treatment options
Thorough discussion of new molecular, biochemical, and brain imaging tests - and how to select the one most likely to reveal a particular disease
Case examples with clinical pearls
Web sites and contact information for patient support groups
Lyon G., Kolodny E.H., Pastores G.M.
2006 Paperback, 500 pages
1. General Aspects of Hereditary Metabolic Diseases of the Nervous System
2. The Neurology of Neonatal Hereditary Metabolic Diseases
3. Early Infantile Progressive Metabolic Encephalopathies: Clinical Problems and Diagnostic Considerations
4. Late Infantile Progressive Genetic Encephalopathies:(Metabolic Encephalopathies of the Second Year of Life)
5. Childhood and Adolescent Hereditary Metabolic Disorders
6. Distinction Between Hereditary Metabolic Diseases and Other Diseases of the Child's Nervous System
7. Visceral and Other Tissue Abnormalities Associated with Hereditary Metabolic Encephalopathies
8. Laboratory Tests for the Diagnosis of Hereditary Metabolic Encephalopathies
9. Treatment and Prevention of Neurometabolic Disorders